Cargando…

Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA

BACKGROUND: Patients diagnosed with ulcerative colitis (UC) associated with primary sclerosis cholangitis (PSC) and sessile serrated adenoma (SSA) are rare. The present study aimed to identify the potential causative gene mutation in a patient with UC associated with PSC and SSA. METHODS: DNA was ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dong, Chen, Dan, Shi, Wen, Liu, Wei, Zhou, Weixun, Qian, Jiaming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449715/
https://www.ncbi.nlm.nih.gov/pubmed/34545326
http://dx.doi.org/10.1155/2021/9936932
_version_ 1784569475970891776
author Wu, Dong
Chen, Dan
Shi, Wen
Liu, Wei
Zhou, Weixun
Qian, Jiaming
author_facet Wu, Dong
Chen, Dan
Shi, Wen
Liu, Wei
Zhou, Weixun
Qian, Jiaming
author_sort Wu, Dong
collection PubMed
description BACKGROUND: Patients diagnosed with ulcerative colitis (UC) associated with primary sclerosis cholangitis (PSC) and sessile serrated adenoma (SSA) are rare. The present study aimed to identify the potential causative gene mutation in a patient with UC associated with PSC and SSA. METHODS: DNA was extracted from the blood sample and tissue sample of SSA, followed by the whole exome sequencing (WES) analysis. Bioinformatics analysis was utilized to predict the deleteriousness of the identified variants. Multiple sequence alignment and conserved protein domain analyses were performed using online software. Sanger sequencing was used to validate the identified variants. Expression and diagnostic analysis of identified mutated genes was performed in the GSE119600 dataset (peripheral blood samples of PSC and UC) and GSE43841 dataset (tumor samples of SSA). RESULTS: In the present study, a total of 842 single nucleotide variants (SNVs) in 728 genes were identified in the blood sample. Two variants, integrin beta 4 (ITGB4) (c.C2503G; p.P835A) and a mucin 3A (MUC3A) (c.C1019T; p.P340L), were further analyzed. MUC3A was associated with inflammatory bowel disease. Sanger sequence in blood revealed that the ITGB4 mutation was fully cosegregated with the result of WES in the patient. Additionally, a variant, tumor protein p53 gene (TP53) (c.86delA; p.N29Tfs(∗)15) was identified in the tissue sample of SSA. Compared to that in normal controls, ITGB4 was upregulated in both UC and PSC, MUC3A was, respectively, upregulated and downregulated in PSC and UC, and TP53 was downregulated in SSA. ITGB4 and TP53 had a potential diagnostic value for UC, PSC and SSA. CONCLUSIONS: The present study demonstrated that the ITGB4 (c.C2503G; p.P835A) and MUC3A (c.C1019T; p.P340L) mutations may be the potential causative variants in a patient with UC associated with PSC and SSA. TP53 (c.86delA; p.N29Tfs(∗)15) mutation may be associated with SSA in this patient.
format Online
Article
Text
id pubmed-8449715
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-84497152021-09-19 Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA Wu, Dong Chen, Dan Shi, Wen Liu, Wei Zhou, Weixun Qian, Jiaming Can J Gastroenterol Hepatol Research Article BACKGROUND: Patients diagnosed with ulcerative colitis (UC) associated with primary sclerosis cholangitis (PSC) and sessile serrated adenoma (SSA) are rare. The present study aimed to identify the potential causative gene mutation in a patient with UC associated with PSC and SSA. METHODS: DNA was extracted from the blood sample and tissue sample of SSA, followed by the whole exome sequencing (WES) analysis. Bioinformatics analysis was utilized to predict the deleteriousness of the identified variants. Multiple sequence alignment and conserved protein domain analyses were performed using online software. Sanger sequencing was used to validate the identified variants. Expression and diagnostic analysis of identified mutated genes was performed in the GSE119600 dataset (peripheral blood samples of PSC and UC) and GSE43841 dataset (tumor samples of SSA). RESULTS: In the present study, a total of 842 single nucleotide variants (SNVs) in 728 genes were identified in the blood sample. Two variants, integrin beta 4 (ITGB4) (c.C2503G; p.P835A) and a mucin 3A (MUC3A) (c.C1019T; p.P340L), were further analyzed. MUC3A was associated with inflammatory bowel disease. Sanger sequence in blood revealed that the ITGB4 mutation was fully cosegregated with the result of WES in the patient. Additionally, a variant, tumor protein p53 gene (TP53) (c.86delA; p.N29Tfs(∗)15) was identified in the tissue sample of SSA. Compared to that in normal controls, ITGB4 was upregulated in both UC and PSC, MUC3A was, respectively, upregulated and downregulated in PSC and UC, and TP53 was downregulated in SSA. ITGB4 and TP53 had a potential diagnostic value for UC, PSC and SSA. CONCLUSIONS: The present study demonstrated that the ITGB4 (c.C2503G; p.P835A) and MUC3A (c.C1019T; p.P340L) mutations may be the potential causative variants in a patient with UC associated with PSC and SSA. TP53 (c.86delA; p.N29Tfs(∗)15) mutation may be associated with SSA in this patient. Hindawi 2021-09-10 /pmc/articles/PMC8449715/ /pubmed/34545326 http://dx.doi.org/10.1155/2021/9936932 Text en Copyright © 2021 Dong Wu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wu, Dong
Chen, Dan
Shi, Wen
Liu, Wei
Zhou, Weixun
Qian, Jiaming
Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA
title Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA
title_full Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA
title_fullStr Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA
title_full_unstemmed Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA
title_short Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA
title_sort whole exome sequencing identifies two novel mutations in a patient with uc associated with psc and ssa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449715/
https://www.ncbi.nlm.nih.gov/pubmed/34545326
http://dx.doi.org/10.1155/2021/9936932
work_keys_str_mv AT wudong wholeexomesequencingidentifiestwonovelmutationsinapatientwithucassociatedwithpscandssa
AT chendan wholeexomesequencingidentifiestwonovelmutationsinapatientwithucassociatedwithpscandssa
AT shiwen wholeexomesequencingidentifiestwonovelmutationsinapatientwithucassociatedwithpscandssa
AT liuwei wholeexomesequencingidentifiestwonovelmutationsinapatientwithucassociatedwithpscandssa
AT zhouweixun wholeexomesequencingidentifiestwonovelmutationsinapatientwithucassociatedwithpscandssa
AT qianjiaming wholeexomesequencingidentifiestwonovelmutationsinapatientwithucassociatedwithpscandssa